|
|
- NHS Regional Offices
- NHS Foundation Trusts (England) - Medical Director
- NHS Trusts (England) - Medical Director
|
|
|
- MHRA (Medicines) Drug Alerts (Various Recipients)
- Other contacts
- Independent Healthcare Providers (registered with CAS)
- Clinical Commissioning Groups
- NHS Foundation Trusts (England) - Chief Executive
- MHRA (Medicines) Drug Alerts - Non-NHS Recipients
- Territorial CMOs in Northern Ireland, Scotland & Wales
- Regional Directors of Public Health
- Director of Public Health
- NHS Trusts (England) - Chief Executive
- GP - Locum
- NHS 111 and Out of hours providers
- Dispensing GP Practices
- DHSC Supply Disruption - Medicines
- Primary Care Networks
|
| Action category: |
|
Class 3: Action within 5 days
|
| Title: |
|
CLASS 3, DRUG ALERT, ACTION WITHIN 5 DAYS, ACCORD HEALTHCARE LIMITED, IRINOTECAN HYDROCHLORIDE 20MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION (5ML VIAL), PL 20075/0443
|
| Broadcast content: |
|
Accord Healthcare Limited is recalling a specific batch (X21343) as a precautionary measure due to the observation of precipitation in the solution in the same batch marketed in another country (Malta). No complaints or adverse reaction reports have been received by the company to date for the UK product.
Advice to healthcare professionals: Stop supplying the affected batch immediately. Quarantine all remaining stock and return these to your supplier using your supplier's approved process.
Full details of the drug alert are included in the attached PDF file. Please forward to listed recipients. This information is also published on the MHRA website https://www.gov.uk/drug-device-alerts.
|
| Additional information: |
|
NHS England and NHS Improvement Regional Offices: Please cascade this alert to Community Pharmacy.
GP Practices: Please note this alert is relevant to Dispensing Practices only.
|
| Cascade to: |
|
- #DISPENSING GP#
- #HospitalPharmacy#
- #COMMUNITYPHARMACISTS#
|